Stopped-Flow Microperfusion Studies of Urate Absorption from the Rat Proximal Tubule

E. J. Weinman, S. C. Sansom, D. A. Steplock, H. Babino, H. O. Senekjian, T. F. Knight

Research output: Contribution to journalArticle

Abstract

The absorptive flux of [2-14C]urate in the rat proximal tubule was examined using stopped-flow and continuous-flow microperfusion techniques. In the stopped-flow studies, the luminal perfusion was a steady-state equilibrium solution and the luminal contact time was 60 sec. The ratio of disintegrations per minute (dpm) of urate in the reaspirated sample to the initial solution (C/I) was 0.42 ± 0.02 in control experiments. The addition of either phloridzin or p-chloromercuribenzoate to the perfusion solution resulted in significantly higher C/I ratios of 0.52 ± 0.03 (P < 0.05) and 0.61 ± 0.006 (P < 0.01), respectively. Substitution of choline for sodium in the perfusion solution or the addition of probenecid did not significantly change the C/I ratio. In continuous-flow microperfusion studies, the fractional absorption of urate from an isotonic saline solution averaged 10.2 ± 0.8%/mm tubule and was significantly inhibited by the addition of probenecid to the perfusion solution. Urate absorption from a steady-state perfusion solution averaged 4.7 ± 1.0%/mm tubule (P < 0.01 compared to the saline solution) and was not affected by the addition of probenecid. These studies indicate that the presence of either phloridzin or p-chloromercuribenzoate in the solution bathing the luminal side of the rat proximal tubule cells inhibits urate absorption. Neither the substitution of choline for sodium in the perfusion solution nor the addition of probenecid to the perfusion solution had any significant effect. The failure to demonstrate an effect of probenecid in the stopped-flow studies may have been due to the requirement to use a non-water absorbing solution. When water absorption is permitted to occur, the addition of probenecid to the perfusion solution inhibited urate absorption.

Original languageEnglish (US)
Pages (from-to)540-544
Number of pages5
JournalProceedings of the Society for Experimental Biology and Medicine
Volume164
Issue number4
DOIs
StatePublished - Sep 1980

Fingerprint

Uric Acid
Rats
Probenecid
Perfusion
Chloromercuribenzoates
Phlorhizin
Choline
Sodium Chloride
Substitution reactions
Sodium
Isotonic Solutions
Disintegration
Water absorption
Fluxes
Water

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Stopped-Flow Microperfusion Studies of Urate Absorption from the Rat Proximal Tubule. / Weinman, E. J.; Sansom, S. C.; Steplock, D. A.; Babino, H.; Senekjian, H. O.; Knight, T. F.

In: Proceedings of the Society for Experimental Biology and Medicine, Vol. 164, No. 4, 09.1980, p. 540-544.

Research output: Contribution to journalArticle

Weinman, E. J. ; Sansom, S. C. ; Steplock, D. A. ; Babino, H. ; Senekjian, H. O. ; Knight, T. F. / Stopped-Flow Microperfusion Studies of Urate Absorption from the Rat Proximal Tubule. In: Proceedings of the Society for Experimental Biology and Medicine. 1980 ; Vol. 164, No. 4. pp. 540-544.
@article{4e25774733dc4eb7aa2e58539aec6dea,
title = "Stopped-Flow Microperfusion Studies of Urate Absorption from the Rat Proximal Tubule",
abstract = "The absorptive flux of [2-14C]urate in the rat proximal tubule was examined using stopped-flow and continuous-flow microperfusion techniques. In the stopped-flow studies, the luminal perfusion was a steady-state equilibrium solution and the luminal contact time was 60 sec. The ratio of disintegrations per minute (dpm) of urate in the reaspirated sample to the initial solution (C/I) was 0.42 ± 0.02 in control experiments. The addition of either phloridzin or p-chloromercuribenzoate to the perfusion solution resulted in significantly higher C/I ratios of 0.52 ± 0.03 (P < 0.05) and 0.61 ± 0.006 (P < 0.01), respectively. Substitution of choline for sodium in the perfusion solution or the addition of probenecid did not significantly change the C/I ratio. In continuous-flow microperfusion studies, the fractional absorption of urate from an isotonic saline solution averaged 10.2 ± 0.8{\%}/mm tubule and was significantly inhibited by the addition of probenecid to the perfusion solution. Urate absorption from a steady-state perfusion solution averaged 4.7 ± 1.0{\%}/mm tubule (P < 0.01 compared to the saline solution) and was not affected by the addition of probenecid. These studies indicate that the presence of either phloridzin or p-chloromercuribenzoate in the solution bathing the luminal side of the rat proximal tubule cells inhibits urate absorption. Neither the substitution of choline for sodium in the perfusion solution nor the addition of probenecid to the perfusion solution had any significant effect. The failure to demonstrate an effect of probenecid in the stopped-flow studies may have been due to the requirement to use a non-water absorbing solution. When water absorption is permitted to occur, the addition of probenecid to the perfusion solution inhibited urate absorption.",
author = "Weinman, {E. J.} and Sansom, {S. C.} and Steplock, {D. A.} and H. Babino and Senekjian, {H. O.} and Knight, {T. F.}",
year = "1980",
month = "9",
doi = "10.3181/00379727-164-40913",
language = "English (US)",
volume = "164",
pages = "540--544",
journal = "Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)",
issn = "1535-3702",
publisher = "Society for Experimental Biology and Medicine",
number = "4",

}

TY - JOUR

T1 - Stopped-Flow Microperfusion Studies of Urate Absorption from the Rat Proximal Tubule

AU - Weinman, E. J.

AU - Sansom, S. C.

AU - Steplock, D. A.

AU - Babino, H.

AU - Senekjian, H. O.

AU - Knight, T. F.

PY - 1980/9

Y1 - 1980/9

N2 - The absorptive flux of [2-14C]urate in the rat proximal tubule was examined using stopped-flow and continuous-flow microperfusion techniques. In the stopped-flow studies, the luminal perfusion was a steady-state equilibrium solution and the luminal contact time was 60 sec. The ratio of disintegrations per minute (dpm) of urate in the reaspirated sample to the initial solution (C/I) was 0.42 ± 0.02 in control experiments. The addition of either phloridzin or p-chloromercuribenzoate to the perfusion solution resulted in significantly higher C/I ratios of 0.52 ± 0.03 (P < 0.05) and 0.61 ± 0.006 (P < 0.01), respectively. Substitution of choline for sodium in the perfusion solution or the addition of probenecid did not significantly change the C/I ratio. In continuous-flow microperfusion studies, the fractional absorption of urate from an isotonic saline solution averaged 10.2 ± 0.8%/mm tubule and was significantly inhibited by the addition of probenecid to the perfusion solution. Urate absorption from a steady-state perfusion solution averaged 4.7 ± 1.0%/mm tubule (P < 0.01 compared to the saline solution) and was not affected by the addition of probenecid. These studies indicate that the presence of either phloridzin or p-chloromercuribenzoate in the solution bathing the luminal side of the rat proximal tubule cells inhibits urate absorption. Neither the substitution of choline for sodium in the perfusion solution nor the addition of probenecid to the perfusion solution had any significant effect. The failure to demonstrate an effect of probenecid in the stopped-flow studies may have been due to the requirement to use a non-water absorbing solution. When water absorption is permitted to occur, the addition of probenecid to the perfusion solution inhibited urate absorption.

AB - The absorptive flux of [2-14C]urate in the rat proximal tubule was examined using stopped-flow and continuous-flow microperfusion techniques. In the stopped-flow studies, the luminal perfusion was a steady-state equilibrium solution and the luminal contact time was 60 sec. The ratio of disintegrations per minute (dpm) of urate in the reaspirated sample to the initial solution (C/I) was 0.42 ± 0.02 in control experiments. The addition of either phloridzin or p-chloromercuribenzoate to the perfusion solution resulted in significantly higher C/I ratios of 0.52 ± 0.03 (P < 0.05) and 0.61 ± 0.006 (P < 0.01), respectively. Substitution of choline for sodium in the perfusion solution or the addition of probenecid did not significantly change the C/I ratio. In continuous-flow microperfusion studies, the fractional absorption of urate from an isotonic saline solution averaged 10.2 ± 0.8%/mm tubule and was significantly inhibited by the addition of probenecid to the perfusion solution. Urate absorption from a steady-state perfusion solution averaged 4.7 ± 1.0%/mm tubule (P < 0.01 compared to the saline solution) and was not affected by the addition of probenecid. These studies indicate that the presence of either phloridzin or p-chloromercuribenzoate in the solution bathing the luminal side of the rat proximal tubule cells inhibits urate absorption. Neither the substitution of choline for sodium in the perfusion solution nor the addition of probenecid to the perfusion solution had any significant effect. The failure to demonstrate an effect of probenecid in the stopped-flow studies may have been due to the requirement to use a non-water absorbing solution. When water absorption is permitted to occur, the addition of probenecid to the perfusion solution inhibited urate absorption.

UR - http://www.scopus.com/inward/record.url?scp=0019149830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019149830&partnerID=8YFLogxK

U2 - 10.3181/00379727-164-40913

DO - 10.3181/00379727-164-40913

M3 - Article

C2 - 7413674

AN - SCOPUS:0019149830

VL - 164

SP - 540

EP - 544

JO - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

JF - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

SN - 1535-3702

IS - 4

ER -